These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 19028872)

  • 21. Soluble epoxide hydrolase: a novel target for the treatment of hypertension.
    Fang X
    Recent Pat Cardiovasc Drug Discov; 2006 Jan; 1(1):67-72. PubMed ID: 18221075
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting epoxides for organ damage in hypertension.
    Imig JD
    J Cardiovasc Pharmacol; 2010 Oct; 56(4):329-35. PubMed ID: 20531214
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of sEH via stabilizing the level of EETs alleviated Alzheimer's disease through GSK3β signaling pathway.
    Sun CP; Zhang XY; Zhou JJ; Huo XK; Yu ZL; Morisseau C; Hammock BD; Ma XC
    Food Chem Toxicol; 2021 Oct; 156():112516. PubMed ID: 34411643
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dual inhibition of cyclooxygenase-2 and soluble epoxide hydrolase synergistically suppresses primary tumor growth and metastasis.
    Zhang G; Panigrahy D; Hwang SH; Yang J; Mahakian LM; Wettersten HI; Liu JY; Wang Y; Ingham ES; Tam S; Kieran MW; Weiss RH; Ferrara KW; Hammock BD
    Proc Natl Acad Sci U S A; 2014 Jul; 111(30):11127-32. PubMed ID: 25024195
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytochrome P450 eicosanoids are activators of peroxisome proliferator-activated receptor alpha.
    Ng VY; Huang Y; Reddy LM; Falck JR; Lin ET; Kroetz DL
    Drug Metab Dispos; 2007 Jul; 35(7):1126-34. PubMed ID: 17431031
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of Cytochrome p450 and Soluble Epoxide Hydrolase Enzymes and Their Associated Metabolites in the Pathogenesis of Diabetic Cardiomyopathy.
    Maayah ZH; McGinn E; Al Batran R; Gopal K; Ussher JR; El-Kadi AOS
    J Cardiovasc Pharmacol; 2019 Sep; 74(3):235-245. PubMed ID: 31306370
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting soluble epoxide hydrolase for inflammation and pain - an overview of pharmacology and the inhibitors.
    Pillarisetti S; Khanna I
    Inflamm Allergy Drug Targets; 2012 Apr; 11(2):143-58. PubMed ID: 22280237
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Soluble epoxide hydrolase inhibition reveals novel biological functions of epoxyeicosatrienoic acids (EETs).
    Inceoglu B; Schmelzer KR; Morisseau C; Jinks SL; Hammock BD
    Prostaglandins Other Lipid Mediat; 2007 Jan; 82(1-4):42-9. PubMed ID: 17164131
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Soluble epoxide hydrolase gene deletion is protective against experimental cerebral ischemia.
    Zhang W; Otsuka T; Sugo N; Ardeshiri A; Alhadid YK; Iliff JJ; DeBarber AE; Koop DR; Alkayed NJ
    Stroke; 2008 Jul; 39(7):2073-8. PubMed ID: 18369166
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epoxyeicosanoids in hypertension.
    Imig JD
    Physiol Res; 2019 Oct; 68(5):695-704. PubMed ID: 31475560
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epoxides and soluble epoxide hydrolase in cardiovascular physiology.
    Imig JD
    Physiol Rev; 2012 Jan; 92(1):101-30. PubMed ID: 22298653
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiac Disease Alters Myocardial Tissue Levels of Epoxyeicosatrienoic Acids and Key Proteins Involved in Their Biosynthesis and Degradation.
    Aliwarga T; Dinh JC; Heyward S; Prasad B; Gharib SA; Lemaitre RN; Sotoodehnia N; Totah RA
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Attenuation of tobacco smoke-induced lung inflammation by treatment with a soluble epoxide hydrolase inhibitor.
    Smith KR; Pinkerton KE; Watanabe T; Pedersen TL; Ma SJ; Hammock BD
    Proc Natl Acad Sci U S A; 2005 Feb; 102(6):2186-91. PubMed ID: 15684051
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of Chronic Pancreatitis and Murine Pancreatic Intraepithelial Neoplasia by a Dual Inhibitor of c-RAF and Soluble Epoxide Hydrolase in LSL-KrasG¹²D/Pdx-1-Cre Mice.
    Liao J; Hwang SH; Li H; Liu JY; Hammock BD; Yang GY
    Anticancer Res; 2016 Jan; 36(1):27-37. PubMed ID: 26722025
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Soluble epoxide hydrolase inhibitor 1-trifluoromethoxyphenyl-3- (1-propionylpiperidin-4-yl) urea attenuates bleomycin-induced pulmonary fibrosis in mice.
    Zhou Y; Yang J; Sun GY; Liu T; Duan JX; Zhou HF; Lee KS; Hammock BD; Fang X; Jiang JX; Guan CX
    Cell Tissue Res; 2016 Feb; 363(2):399-409. PubMed ID: 26310139
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacological inhibition of the soluble epoxide hydrolase-from mouse to man.
    Revermann M
    Curr Opin Pharmacol; 2010 Apr; 10(2):173-8. PubMed ID: 20079692
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DiscrEET regulators of homeostasis: epoxyeicosatrienoic acids, cytochrome P450 epoxygenases and vascular inflammation.
    Fleming I
    Trends Pharmacol Sci; 2007 Sep; 28(9):448-52. PubMed ID: 17764757
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design and discovery of soluble epoxide hydrolase inhibitors for the treatment of cardiovascular diseases.
    Duflot T; Roche C; Lamoureux F; Guerrot D; Bellien J
    Expert Opin Drug Discov; 2014 Mar; 9(3):229-43. PubMed ID: 24490654
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Soluble epoxide hydrolase and lipid metabolism].
    Ma XX; Liu Y; Zhu Y
    Sheng Li Ke Xue Jin Zhan; 2010 Aug; 41(4):267-71. PubMed ID: 21416942
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel role for P450 eicosanoids in the neurogenic control of cerebral blood flow in the rat.
    Iliff JJ; Close LN; Selden NR; Alkayed NJ
    Exp Physiol; 2007 Jul; 92(4):653-8. PubMed ID: 17639071
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.